Background/Aims: There are controversies for the management of esophageal neoplasia due to its variety among countries. In this study, we tried to uncover the different managements on esophageal neoplasia between Korea, Singapore, and Japan. Materials and Methods: We administered ten questionnaires to Korean, Japanese, and Singaporean endoscopists. The questionnaire consisted of endoscopic images from ten different esophageal neoplasms. Results: For Barrett esophagus (BE) with adenocarcinoma (P=0.013) and well-differentiated-type squamous cell carcinoma (P=0.007), all (100%) of the Japanese endoscopists selected endoscopic resection as treatment, whereas 25∼40% of the Korean and Singaporean endoscopists selected surgical resection. For BE with low grade dysplasia (P=0.002) and flat-type squamous dysplasia (P＜0.001), observation without endoscopic treatment was preferred in Japan, whereas endoscopic treatment was preferred in Korea and Singapore. Similar findings between three countries were; (i) medication for BE, (ii) endoscopic treatment for BE with high grade dysplasia and elevated-type squamous dysplasia, and (iii) operation for moderately-differentiated or poorly-differentiated typed SCC. Conclusions: Our survey addresses different managements on esophageal neoplasia between Korea, Singapore, and Japan. More advanced or aggressive treatments are preferred in Korea and Singapore than in Japan for the management of BE with LGD, flat-type squamous dysplasia, BE with adenocarcinoma, and WD-typed SCC. 
INTRODUCTION
Apart from the different incidences of squamous cell carcinoma (SCC) and esophageal adenocarcinoma among the countries, 1 there is a large discrepancy in the diagnostic criterion for dysplasia and cancer. 2, 3 According to the World Health Organization criteria, esophageal cancer is diagnosed when the tumor invades the lamina propria mucosa or further. If the tumor is located within the epithelium, it is diagnosed as low grade dysplasia (LGD) or high grade dysplasia (HGD), depending on the thickness of basaloid type neoplastic cells in the 
MATERIALS AND METHODS

Questionnaire
All questions were presented in one page and the survey took approximately 5∼10 minutes to complete. All survey results were anonymous. The questionnaire included questions about each participant's background; name of the hospital and years of GI endoscopic practice.
Ten endoscopic scenarios were prepared as follows: (i) short-segment Barrett esophagus (BE), (ii) long-segment BE, 
The institutional review boards of Konkuk University
Medical Center approved this survey study (KUH 1010252). 
Study subjects
GI
Statistical analysis
For categorical variables, the counts (n) and the percentages (%) are provided. 
RESULTS
A total of 41 endoscopists (24 Japanese, 12 Korean, and 5
Singaporean endoscopists) completed answering ten questions.
The most frequent answers for each questionaires are summarized in Table 1 . The years of GI practice was not different among three countries (P=0.689) ( Table 2 ).
Treatment for BE
All and 95.1% of the participants selected medication as a treatment for short-segment BE and long-segment BE, respectively (Table 1) . With regard to BE with LGD, some Korean (66.7%) and Singaporean (40%) endoscopists selected endoscopic ablation or endoscopic resection as a treatment, which was a significantly different finding from the Japanese endoscopists (P=0.002) (Fig. 1A) . For BE with HGD, most of the participants (87.8%) selected endoscopic resection as a treatment (Table 1) , and there was no difference among three countries (P=0.081). For BE with adenocarcinoma, some Korean (33.3%) and Singaporean (20%) endoscopists selected surgical resection as a treatment, whereas all of the Japanese endoscopists selected endoscopic resection (P=0.013) (Fig. 1B) . Fig. 1 . Different managements between Korea, Singapore, and Japan for BE with LGD (A), BE with adenocarcinoma (B), flat-type squamous dysplasia (C), and WD-type SCC (D). K, Korea; S, Singapore; J, Japan.
Treatment for squamous dysplasia
Most of the participants (92.7%) selected endoscopic resection as a treatment for the elevated-type squamous dysplasia, and there was no difference among three countries (P=0.682).
For flat-type squamous dysplasia, endoscopic resection was preferred in Korea (83.3%) and Singapore (80%), but not in Japan (29.2%). Most of the Japanese endoscopists preferred observation without endoscopic treatment (P＜0.001) (Fig. 1C) .
Treatment for SCC
For early-staged SCC, either endoscopic resection or surgical resection was preferred as a treatment (Table 2 ). For WD-type SCC, 85.4% of the participants selected endoscopic resection as a treatment (Table 1) . Notably, all the Japanese endoscopists (100%) selected endoscopic resection, whereas some Korean (33.3%) and Singaporean (40%) endoscopists selected surgical resection (P=0.007) (Fig. 1D ).
For MD-type SCC, surgical resection (51.2%) and endoscopic resection (43.9%) were the most common answers, and there was no difference among three countries (P=0.800). For PD-type SCC, surgical resection was the most answer (61%) ( Table 1) .
DISCUSSION
To the best of our knowledge, this is the first comparison study between Korea, Singapore, and Japan on the managements for BE, esophageal dysplasia, and early-type esophageal cancer. It is interesting that several significant differences were noticed among three countries for the management of (i) BE with LGD, (ii) BE with adenocarcinoma, (iii) flat-type squamous dysplasia, and (iv) WD-type SCC. We assume that different diagnostic criteria on dysplasia and cancer, and abundant Japanese literatures on ESD have led to such discrepancy between Japan and other two countries; Singapore and Korea.
It is interesting that all of the Japanese endoscopists preferred endoscopic resection for BE with adenocarcinoma and WD-type SCC, whereas 25∼40% of the Korean and Singaporean endoscopists preferred surgical resection. The goal of endoscopic treatment is to completely remove the esophageal lesions with less morbidity. Therefore, the degree of differentiation and the presence of vascular or lymphatic invasion which are related to the risk of lymph node metastasis, should be considered before endoscopic resection. It is known that lymph node metastasis is very rare in m1 (epithelium) and m2
(lamina propria) cancers. [5] [6] [7] Recent Japanese expanded indication recommends ESD for m3 (cancers reaching muscularis mucosa) and sm1 (upper 1/3 layer of submucosa) cancers, 8 but it should be taken seriously because of high potential lymph node involvement. The risk of nodal metastases is low when infiltration is less than 200μm in esophageal SCC, 9 whereas a submucosal infiltration micrometric cutoff of 500μm has been proposed in esophageal adenocarcinoma due to its lower risk of nodal metastases. 10, 11 Taken as a whole, these Japanese studies might have led our Japanese participants to select endoscopic resection instead of surgery in BE with adenocarcinoma and WD-type SCC.
Another interesting finding in this study is that, for BE with
LGD and flat-type squamous dysplasia, medication was preferred in Japan, whereas endoscopic treatment was preferred in Korea and Singapore. Such differences might be due to different definitions for dysplasia in Japan. Dysplasia is diagnosed for non-invasive neoplastic proliferation in Western criteria, but in Japan, there is a resistance to use the term HGD, because it is consisted of severe dysplasia and carcinoma in situ (CIS). 2, 3, 12 Japanese pathologists use the terms intraepithelial carcinoma or CIS for squamous esophageal lesions, instead of distinguishing invasion and non-invasion for glandular lesions. 5 In summary, we assume that there is a tendency among Japanese endoscopists to consider dysplasia as less severe form than those of HGD diagnosed in other countries.
Limitations of our study are: (i) that the number of participants is small and (ii) that we could not provide variable cases for each histopathology. For example, near half of the Japanese endoscopists preferred endoscopic resection for PD-type SCC, but we could not show from which size or from which depth, the operation could be preferred instead of endoscopic resection in PD-type SCC. A large-sized study with various SCC cases of each cell-type will verify this issue.
In conclusion, this study addresses different managements for esophageal epithelial neoplasia between Korea, Singapore, and Japan. One-step advanced or aggressive treatment is preferred in Korea and Singapore than in Japan with regard to BE with
LGD, flat-type squamous dysplasia, BE with adenocarcinoma, and WD-typed SCC. For BE with adenocarcinoma and WD-type SCC, endoscopic resection is preferred in Japan, whereas operations are preferred in among Korean and Singaporean endoscopists. For BE with LGD and flat-type squamous dysplasia, medication was preferred in Japan, whereas endoscopic treatment was preferred in Korea and Singapore. We assume that such discrepancy comes from abundant Japanese literatures on ESD and different diagnostic criteria for dysplasia and cancer in Japan comparable to Singapore and Korea.
